Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENCHMRK-1: Raltegravir in treatment-experienced HIV
NCT00293267Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Started Feb 2006; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00293267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293267.